Roche Foundation Medicine are collaborating to pioneer progress in precision medicine for cancer patients around the world As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation and experience in cancer profiling, together we are: 1 Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials